Appointments are open to the all groups:
- Ages 18+ (Moderna & J&J)
- Ages 5+ (Pfizer)
CDC recommends Pfizer, Moderna vaccines over J&J’s
The US Centers for Disease Control and Prevention changed its recommendations for Covid-19 vaccines Thursday to make clear that shots made by Moderna and Pfizer/BioNTech are preferred over Johnson & Johnson’s vaccine.
The new recommendation: “mRNA vaccines are preferred over the Janssen Covid-19 vaccine for the prevention of Covid-19 for those 18 years of age and over.”Earlier Thursday, the CDC’s Advisory Committee on Immunization Practices endorsed the updated recommendation after hearing new data indicating that a rare blood clotting syndrome is more common among people who recently got a J&J vaccine than previously believed.
CDC Director Dr. Rochelle Walensky accepted the updated recommendation within hours.The CDC has logged 54 cases in the US of thrombosis with thrombocytopenia syndrome or TTS in the US since the vaccine became available. Nine people have died — seven women and two men.
Rates are higher than previously estimated among both men and women, the CDC’s Dr. Isaac See told the meeting. While only a few cases have been seen for every million people vaccinated by age group, they are higher than what was believed when vaccine advisers were last briefed.
CDC recommends Pfizer/BioNTech Covid-19 vaccine boosters for children as young as 12
The US Centers for Disease Control and Prevention updated its recommendations for the Pfizer/BioNTech Covid-19 vaccine booster on Wednesday to include children as young as 12, at least five months after they finish the primary vaccine series.On Monday, the FDA expanded the emergency use authorization for Pfizer’s Covid-19 vaccine boosters to children ages 12 to 15. The CDC’s Advisory Committee on Immunization Practices (ACIP) voted 13-1 earlier Wednesday in favor of recommending the expanded use of Covid-19 boosters for children in this age group.The CDC had authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in ages 16 and 17 in December.”It is critical that we protect our children and teens from COVID-19 infection and the complications of severe disease,” CDC Director Dr. Rochelle Walensky said in a news release. “Today, I endorsed ACIP’s vote to expand eligibility and strengthen our recommendations for booster doses. We now recommend that all adolescents aged 12-17 years should receive a booster shot 5 months after their primary series. This booster dose will provide optimized protection against COVID-19 and the Omicron variant. I encourage all parents to keep their children up to date with CDC’s COVID-19 vaccine recommendations.”
Data Update (2/10/2022):
- As of 2/9/22, MCDPH updated methods used to calculate the number of people who have received at least 1 dose of vaccine and/or are fully vaccinated (i.e., completed their primary series).
- In alignment with CDC, MCDPH vaccination definitions are:
- Received at least 1 dose of vaccine: all persons who have received at least one dose of any vaccine type
- Fully vaccinated (i.e., completed the primary series): all persons who have received one dose of Johnson & Johnson or two doses of Moderna/Pfizer separated by the appropriate number of days. A person must receive two doses of vaccine by the same manufacturer.
- These updates improved vaccination data quality by removing duplicates, however, some jurisdictions/ZIP codes will notice a slightly lower vaccinated population percentage in this week’s data compared to last. The majority of ZIP codes that saw a decrease in their vaccination rates declined by less than 1%.
- Additionally, ADHS is assisting our data processes by providing geocoded data to all counties. This increases the accuracy of a person’s county of residence, and may have led to a reduction in the total number of vaccine doses previously assigned to Maricopa County. A shift in software used to geocode by ADHS may also have contributed to some of these small differences.
- We anticipate using the same methods to define vaccinated persons and geocode vaccination data going forward, which means you will be able to compare data from week to week.